Compile Data Set for Download or QSAR
maximum 50k data
Found 63 Enz. Inhib. hit(s) with all data for entry = 10956
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580943((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  47nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM581006((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  11.6nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580946((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  80.5nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580946((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  387nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580948((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  53.6nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580948((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  7.05E+3nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580950((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  142nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580951((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  2.40nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580952((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  90.3nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580953((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  43.4nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580954((4S,7S,9aS)-8,8-dimethyl-4-[(2S)-2-(methylamino)pr...)
Affinity DataEC50:  324nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580955((4S,7S,9aS)-8,8-dimethyl-4-[(2S)-2-(methylamino)pr...)
Affinity DataEC50:  6.80nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580956((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  9.30nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580956((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  8.40nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580958((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  15.3nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580959((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  10.1nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580960((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  20.7nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580961((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  22.3nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580962((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  9.40nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580963((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  11.9nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580964((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  13nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580965((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  8.80nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580966((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  55.5nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580967((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  47.9nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580968((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  61.8nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580969((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  69.1nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580970((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  52.2nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580971((2S)—N-[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-{[(S...)
Affinity DataEC50:  53.7nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580972((2S)-2-{[(4S,7S,9aS)-8,8-dimethyl-4-[(2S)-2-(methy...)
Affinity DataEC50:  89.5nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580973((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  65.4nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580974((4S,7S,9aS)—N—((S)-2-((6-((S)-2-((4S,7S,...)
Affinity DataEC50:  25.8nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580975((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  166nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580976((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  5.5nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580977((4S,7S,9aS)—N—((S)-2-((6-((S)-2-((4S,7S,...)
Affinity DataEC50:  36.3nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580978((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  9nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580979((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  9.5nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580980((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  10.9nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580981((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  50.7nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580982((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  51.8nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580983((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  6.10nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580984((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  51.6nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580985((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  6.80nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580986((4S,4′S,7S,7′S,9aS,9a′S)—N,...)
Affinity DataEC50:  43.4nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580987((4S,7S,9aS)-N-[(1R,2R)-2-({[4-({[(1R,2R)-1-[(4S,7S...)
Affinity DataEC50:  20.4nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580988((4S,7S,9aS)—N-[(1R,2R)-2-({[4-({[(1R,2R)-1-[(...)
Affinity DataEC50:  183nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580989((4S,7S,9aS)—N-[(1R,2R)-2-{4-[(1R,2R)-1-[(4S,7...)
Affinity DataEC50:  127nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580990((4S,7S,9aS)-N-[(1R,2R)-2-{4-[(1R,2R)-1-[(4S,7S,9aS...)
Affinity DataEC50:  1.20nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580991((4S,7S,9aS)-N-[(1S,2R)-2-[(8-{[(1S,2R)-1-[(4S,7S,9...)
Affinity DataEC50:  11.6nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580992((4S,7S,9aS)—N-[(1R,2R)-2-[(6-{[(1R,2R)-1-[(4S...)
Affinity DataEC50:  466nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 group M subtyp...)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM580993((4S,7S,9aS)-N-[(1S)-2-[2-(4-{[(2S)-2-{[(4S,7S,9aS)...)
Affinity DataEC50:  95.9nMAssay Description:Jurkat HIV-luciferase clones were maintained in RPMI medium 1640 (Gibco by Life Technologies) containing 10% (vol/vol) fetal bovine serum (SAFC/Sigma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 63 total ) | Next | Last >>
Jump to: